HIGHLIGHTS
- who: Tomas Majtan et al. from the Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States have published the research: Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria, in the Journal: (JOURNAL) of April/21,/2017
- what: The aim of this study was to design and characterize a PEG htCBS conjugate that would exhibit high reproducibility and control during manufacturing as well as display long-term efficacy. The data presented in this study show steady progress toward development of ERT for HCU and as such should be a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.